Skip to main content

Jury Orders J&J To Pay $9M In Talc-Asbestos Case

Jury Orders J&J To Pay $9M In Talc-Asbestos Case

Jury Orders J&J To Pay $9M In Talc-Asbestos Case

Introduction

On Thursday, a Miami jury ordered Johnson & Johnson (J&J) to pay a Florida-based woman $9 million after finding that their talc-based product caused the woman's mesothelioma. The verdict is considered to be the first in the Sunshine State.

According to the jury, J&J was negligent and sold a defective product, which contained asbestos. The plaintiff will receive $3 million for past medical expenses and $6 million for past and future pain and suffering.

Two days ago, attorneys for J&J and the plaintiff, a 62-year-old woman who had alleged that asbestos in its baby powder caused her mesothelioma, reached settlement bringing a halt to the trial that was underway and had completed opening statements.

Johnson's Baby Powder, one of the most popular products containing talcum powder, is linked to increasing a woman's risk of ovarian cancer if she uses it regularly in the genital area. In a few cases, the cancer tissue was studied using an electron microscope and was found to have talc in it, which supported the claim that the cancer was caused by the body powder and increases the talc-related cancer risk.

Also, Earlier this month, during a different trial, a New Brunswick, New Jersey, jury hit J&J with $750 million in punitive damages, which was immediately reduced to $186 million due to a state cap on punitive damages.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Attorneys Seek Reconsideration of Talc MDL Daubert Ruling

Categories: General

Plaintiffs’ attorneys are urging the U.S. District Judge overseeing the talcum powder lawsuit MDL to reconsider a recent decision for a second round…

Philips resolves DreamStation suits for $1.1B

Categories: Settlements

Dutch medical technology company Philips has finalized a $1.1 billion settlement in the United States to address lawsuits concerning faulty…

FDA OKs Generic OTC Naloxone Spray Approved by FDA

Categories: FDA Related

The FDA has granted approval for Amneal Pharmaceuticals to release a generic 4 mg naloxone hydrochloride nasal spray for over-the-counter (OTC) use, an announcement made in a press release.

Our Legal Drafting Services    
start @ $25 per hour.